UnknownNot Applicable

Turkish Validation of The Drooling Impact Scale

Turkey (Türkiye)30 participantsStarted 2019-11-25

Plain-language summary

The aim of this study is to investigate the reliability and construct validity of the Turkish version of the Drooling Impact Scale in children with cerebral palsy

Who can participate

Age range4 Years – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with unilateral or bilateral cerebral palsy at between the ages of 4-16
✓. Spastic, dyskinetic or mixed type cerebral palsy
✓. GMFCS level 3,4,5
✓. Stable drooling within at least one month

Exclusion criteria

✕. Active infection of salivary glands
✕. Upper respiratory tract infection at the time of testing
✕. History of anticholinergic drug intake in the past three weeks
✕. Occurance of any above between test and re-test assessment that may interfere with the results

What they're measuring

Drooling Impact Scale

Timeframe: Day 0

Drooling Impact Scale

Timeframe: Day 3

Trial details

NCT IDNCT04132765

SponsorMarmara University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-08-30

Contact for this trial

Esra Giray, MD

+905558134394 girayesra@hotmail.com

View on ClinicalTrials.gov More Hypersalivation trials